Targeting AMPK and the Nrf2/HO-1 axis: a promising therapeutic strategy in acute lung injury
Stefan W. Ryter
Abstract
Therapeutic targeting of AMPK can improve acute lung injury via upregulation of the cytoprotective enzyme heme oxygenase-1
Topics & Concepts
MedicineARDSLungPneumoniaSepsisIntensive care medicineInternal medicineHeme Oxygenase-1 and Carbon MonoxideRespiratory Support and MechanismsBurn Injury Management and Outcomes